AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26297883 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% NaF
Number of subjects: 12
Study 26297883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 26297883 — intervention group
Group type: COMPARATOR
Intervention: 1% NaF
Number of subjects: 12
Study 22888075 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ADT and RTH
Number of subjects: 60
Study 22888075 — intervention group
Group type: COMPARATOR
Intervention: RTH only
Number of subjects: 60
Study 21521283 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel (5 or 10 g/daily) plus rhGH (0, 3 or 5 μg/kg/day)
Number of subjects: 108
Study 19396567 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 0
Study 16702472 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE; 0.625 mg; n=5310)
Number of subjects: 10739
Study 16702472 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=5429)
Number of subjects: 10739
Study 16702472 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE; 0.625 mg)
Number of subjects: 10739
Study 15588333 — intervention group
Group type: EXPERIMENTAL
Intervention: Duhuo Jisheng Wan (DJW)
Number of subjects: 200
Study 15588333 — intervention group
Group type: COMPARATOR
Intervention: diclofenac
Number of subjects: 200
Study 11498833 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy to the ipsilateral breast
Number of subjects: 2622
Study 11498833 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) after lumpectomy and radiation therapy
Number of subjects: 2622
Study 11498833 — intervention group
Group type: COMPARATOR
Intervention: Lumpectomy alone
Number of subjects: 2622
Study 11498833 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 2622
Study 9515223 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 100 mg preprandial
Number of subjects: 5
Study 9515223 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 200 mg preprandial
Number of subjects: 5
Study 9515223 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 300 mg preprandial
Number of subjects: 5
Study 9515223 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 200 mg postprandial
Number of subjects: 5
Study 9515223 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 200 mg every 12 hours for 7 days
Number of subjects: 5
Study 8427430 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide + Placebos
Number of subjects: 0
Study 8427430 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide + Ibuprofen
Number of subjects: 0
Study 8427430 — intervention group
Group type: COMPARATOR
Intervention: Placebos + Placebos
Number of subjects: 0
Study 3679703 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg elemental zinc/day
Number of subjects: 15
Study 3679703 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg elemental zinc/day
Number of subjects: 15
Study 3679703 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg elemental zinc/day
Number of subjects: 15
Study 3679703 — intervention group
Group type: COMPARATOR
Intervention: Control group (young females)
Number of subjects: 15
Study 29429948 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-CBT (16 individual therapy sessions, each 1 hour long)
Number of subjects: 116
Study 29429948 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (treatment as usual)
Number of subjects: 116
Study 27222342 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine solution during 180 min of stationary cycling
Number of subjects: 11
Study 27222342 — intervention group
Group type: COMPARATOR
Intervention: Placebo during 180 min of stationary cycling
Number of subjects: 11
Study 24299727 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF (10 μg/kg/d) intravenously for 5 consecutive days
Number of subjects: 41
Study 24299727 — intervention group
Group type: COMPARATOR
Intervention: Control group (no G‐CSF administration)
Number of subjects: 41
Study 24299727 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF group
Number of subjects: 41
Study 24299727 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 24354675 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean red ginseng (KRG) 500 mg, six capsules twice a day for eight weeks
Number of subjects: 80
Study 24354675 — intervention group
Group type: COMPARATOR
Intervention: Placebo, six capsules twice a day for eight weeks
Number of subjects: 80
Study 24354675 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean red ginseng (KRG)
Number of subjects: 80
Study 20846227 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal pelvic floor muscle exercises (4 sessions of taught training during pregnancy and 8-12 maximal contractions twice daily at home)
Number of subjects: 286
Study 20846227 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 286
Study 18073463 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery (BrA) insonation
Number of subjects: 66
Study 18073463 — intervention group
Group type: EXPERIMENTAL
Intervention: Common carotid artery (CCA) insonation
Number of subjects: 66
Study 18073463 — intervention group
Group type: EXPERIMENTAL
Intervention: Common femoral artery (CFA) insonation
Number of subjects: 66
Study 16033646 — intervention group
Group type: EXPERIMENTAL
Intervention: Information package (intervention arm)
Number of subjects: 1800
Study 16033646 — intervention group
Group type: COMPARATOR
Intervention: No information above that gained during normal practice (control arm)
Number of subjects: 1800
Study 12297896 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine-enriched formula-milk (for preterm neonates)
Number of subjects: 155
Study 12297896 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-milk
Number of subjects: 155
Study 12297896 — intervention group
Group type: COMPARATOR
Intervention: Full term neonates (baseline measurement)
Number of subjects: 155
Study 12297896 — intervention group
Group type: COMPARATOR
Intervention: Full term neonates (historical comparison)
Number of subjects: 155
Study 10077371 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct bronchial artery revascularization
Number of subjects: 25
Study 10077371 — intervention group
Group type: COMPARATOR
Intervention: No direct bronchial artery revascularization
Number of subjects: 25
Study 10077371 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive secretion in the airways
Number of subjects: 25
Study 8824655 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily
Number of subjects: 208
Study 8824655 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily
Number of subjects: 208
Study 8824655 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 208
Study 2033138 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate 0.1% cream, applied once daily
Number of subjects: 48
Study 2033138 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone 1.0% cream, applied twice daily
Number of subjects: 48
Study 7012247 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose ampicillin (100 mg/kg)
Number of subjects: 101
Study 7012247 — intervention group
Group type: COMPARATOR
Intervention: Five-day multiple-dose ampicillin (100 mg/kg per 24 hr)
Number of subjects: 101
Study 30717465 — intervention group
Group type: EXPERIMENTAL
Intervention: Education-based intervention
Number of subjects: 464
Study 28388942 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 323
Study 28388942 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-incision open cholecystectomy (SIOC)
Number of subjects: 323
Study 25395689 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular droperidol (10 mg)
Number of subjects: 584
Study 25395689 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular haloperidol (10 mg)
Number of subjects: 584
Study 25395689 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 584
Study 24740868 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-session lifestyle intervention delivered via 'video-on-demand' cable television
Number of subjects: 306
Study 24740868 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-session lifestyle intervention delivered via 'video-on-demand' cable television with online behavioral support tools
Number of subjects: 306
Study 24740868 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 306
Study 22986010 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (DIS) for at least 120 days
Number of subjects: 209
Study 22986010 — intervention group
Group type: EXPERIMENTAL
Intervention: DIS for <120 days
Number of subjects: 209
Study 22986010 — intervention group
Group type: EXPERIMENTAL
Intervention: >50% adherence to consultations
Number of subjects: 209
Study 22986010 — intervention group
Group type: EXPERIMENTAL
Intervention: More than two phases on each consultation
Number of subjects: 209
Study 22986010 — intervention group
Group type: COMPARATOR
Intervention: Female gender, lower socio‐economic levels, cocaine use, >20 years of consumption, gamma glutamyl transferase values above normal, five or more alcohol-related problems
Number of subjects: 209
Study 22986010 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a full-time job and shorter abstinence time before treatment (until 7 days)
Number of subjects: 209
Study 20067599 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal replacement therapy
Number of subjects: 0
Study 20067599 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-induced nephropathy protection
Number of subjects: 0
Study 20067599 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimization of volume status, haemodynamic parameters, electrolyte and acid-base disturbances
Number of subjects: 0
Study 16368629 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational music
Number of subjects: 58
Study 16368629 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm music
Number of subjects: 58
Study 16368629 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 58
Study 12941676 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/d of micronized 17beta-estradiol (n = 83)
Number of subjects: 167
Study 12941676 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 84)
Number of subjects: 167
Study 11899388 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 given as a 3-hour infusion every 3 weeks
Number of subjects: 18
Study 11899388 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel with trastuzumab
Number of subjects: 18
Study 11899388 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 60-100 mg/m2 given as a 1-hour infusion every 3 weeks
Number of subjects: 18
Study 11899388 — intervention group
Group type: COMPARATOR
Intervention: Taxanes as a component of first-line therapy
Number of subjects: 18
Study 11899388 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxanes (Paclitaxel and Docetaxel)
Number of subjects: 18
Study 8888110 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (200 mg/day for 6 weeks)
Number of subjects: 12
Study 8888110 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 12
Study 1473367 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP; 200‐300 mg, i.v. b.i.d.) + vancomycin (VAN; 0.5‐1 g, i.v. b.i.d.)
Number of subjects: 58
Study 1473367 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (2 g, i.v. t.i.d.) + gentamicin (1 mg/kg, i.v. t.i.d.)
Number of subjects: 58
Study 6657514 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP) 60 micrograms
Number of subjects: 15
Study 6657514 — intervention group
Group type: COMPARATOR
Intervention: Vehicle solution
Number of subjects: 15
Study 31630465 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided erector spinae plane block using 0.3 mL/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg
Number of subjects: 60
Study 31630465 — intervention group
Group type: COMPARATOR
Intervention: Control group received general anesthesia with bilateral sham erector spinae plane block using 0.3 mL/kg normal saline on each side
Number of subjects: 60
Study 28921547 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide (HP) for 1.5 hours daily for 21 days
Number of subjects: 30
Study 28921547 — intervention group
Group type: COMPARATOR
Intervention: 10% carbamide peroxide (CP) for 4 hours daily for 21 days
Number of subjects: 30
Study 27505216 — intervention group
Group type: EXPERIMENTAL
Intervention: Go/no-go food task
Number of subjects: 133
Study 27505216 — intervention group
Group type: COMPARATOR
Intervention: Go/no-go control task
Number of subjects: 133
Study 25071901 — intervention group
Group type: EXPERIMENTAL
Intervention: rebamipide 100 mg three times per day
Number of subjects: 479
Study 25071901 — intervention group
Group type: COMPARATOR
Intervention: misoprostol 200 μg three times per day
Number of subjects: 479
Study 22916885 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk supplemented with Bifidobacterium lactis Bi‐07 and Lactobacillus acidophilus NCFM, and isomaltooligosaccharide, 480 g/d for 2 weeks
Number of subjects: 100
Study 20708525 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 microg per day)
Number of subjects: 166
Study 20708525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study 20708525 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 166
Study 20708525 — intervention group
Group type: COMPARATOR
Intervention: Selenium supplementation and Placebo
Number of subjects: 166
Study 17767826 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal-softened tube guided by fiberoptic bronchoscope
Number of subjects: 209
Study 17767826 — intervention group
Group type: COMPARATOR
Intervention: Common tube at room temperature (23-26 centigrade)
Number of subjects: 209
Study 16230723 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiseptic catheter (chlorhexidine and silver sulfadiazine)
Number of subjects: 780
Study 16230723 — intervention group
Group type: COMPARATOR
Intervention: Control catheter (standard catheter)
Number of subjects: 780
Study 12110425 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (estradiol plus noretisterone acetate) for 1 year
Number of subjects: 80
Study 12110425 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (jumping and bounding activities) for 1 year
Number of subjects: 80
Study 12110425 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT + Exercise (ExHRT) for 1 year
Number of subjects: 80
Study 12110425 — intervention group
Group type: COMPARATOR
Intervention: Control (Co)
Number of subjects: 80
Study 10543292 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Mannitol (300 mg)
Number of subjects: 12
Study 10543292 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (6%)
Number of subjects: 12
Study 7818312 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic CPB (36 degrees C)
Number of subjects: 30
Study 7818312 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic CPB (28 degrees C)
Number of subjects: 30
Study 7818312 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 2127687 — intervention group
Group type: EXPERIMENTAL
Intervention: Protirelin tartrate (TRH-T)
Number of subjects: 136
Study 2127687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 217789 — intervention group
Group type: EXPERIMENTAL
Intervention: Premarin Intravenous
Number of subjects: 0
Study 217789 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study 31639016 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive health program (medical exercise therapy and lifestyle coaching)
Number of subjects: 552
Study 31639016 — intervention group
Group type: COMPARATOR
Intervention: Longitudinal back pain survey (control group)
Number of subjects: 552
Study 28410525 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS (10Hz)
Number of subjects: 30
Study 28410525 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study 26487563 — intervention group
Group type: EXPERIMENTAL
Intervention: weight-loss program + exercise (WL + E group)
Number of subjects: 55
Study 26487563 — intervention group
Group type: COMPARATOR
Intervention: weight-loss program + sham (WL + S group)
Number of subjects: 55
Study 22516427 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (aspirin 325 mg daily plus clopidogrel 75 mg daily)
Number of subjects: 3020
Study 22516427 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelet therapy (aspirin 325 mg daily plus placebo)
Number of subjects: 3020
Study 22516427 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure targets (<130 mmHg)
Number of subjects: 3020
Study 22516427 — intervention group
Group type: COMPARATOR
Intervention: Usual systolic blood pressure targets (130‐149 mmHg)
Number of subjects: 3020
Study 21496110 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation (EMS) on dominant wrist flexors
Number of subjects: 23
Study 21496110 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional mode of transcutaneous electrical nerve stimulation without contraction)
Number of subjects: 23
Study 19238387 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE‐PVO (group B: n = 14)
Number of subjects: 21
Study 19238387 — intervention group
Group type: COMPARATOR
Intervention: Shunt embolization with coils and/or gelatin‐sponge particles (group A: n = 7)
Number of subjects: 21
Study 16304567 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibro-ejaculation weekly for 3 months (study group)
Number of subjects: 74
Study 16304567 — intervention group
Group type: COMPARATOR
Intervention: Baseline and end of 3-month period vibro-ejaculation (control group)
Number of subjects: 74
Study 12672933 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein intake
Number of subjects: 467
Study 12672933 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate intake
Number of subjects: 467
Study 10732934 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin (600 mg/d) and pyrazinamide (20 mg/kg per day) for 2 months
Number of subjects: 1583
Study 10732934 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid (300 mg/d) for 12 months
Number of subjects: 1583
Study 10732934 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin and pyrazinamide
Number of subjects: 1583
Study 10732934 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid
Number of subjects: 1583
Study 8609128 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (patients after total joint replacement)
Number of subjects: 27
Study 8609128 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (control group before total joint replacement)
Number of subjects: 27
Study 1575846 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine DPNB
Number of subjects: 75
Study 1575846 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroprocaine DPNB (3-minute wait)
Number of subjects: 75
Study 1575846 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroprocaine DPNB (2-minute wait)
Number of subjects: 75
Study 1575846 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroprocaine DPNB (5-minute wait)
Number of subjects: 75
Study 1575846 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonblocked)
Number of subjects: 75
Study 3881228 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (60 mg, single oral dose)
Number of subjects: 2
Study 3881228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 3881228 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 2
Study 30889985 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad (light)
Number of subjects: 14
Study 30889985 — intervention group
Group type: COMPARATOR
Intervention: hard-copy book (control)
Number of subjects: 14
Study 29471303 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of the new kidney allocation system among dialysis facility staff
Number of subjects: 653
Study 29471303 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness by role among staff
Number of subjects: 653
Study 27598552 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of pain education, specific exercises, and graded physical activity training
Number of subjects: 200
Study 27598552 — intervention group
Group type: COMPARATOR
Intervention: Pain education alone (control)
Number of subjects: 200
Study 24988555 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural injections of glucocorticoids plus lidocaine
Number of subjects: 400
Study 24988555 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine alone
Number of subjects: 400
Study 22162540 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine 35-mg MR tablets in fasting state
Number of subjects: 36
Study 22162540 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine 35-mg MR tablets in fed state
Number of subjects: 36
Study 22162540 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation in fasting state
Number of subjects: 36
Study 22162540 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation in fed state
Number of subjects: 36
Study 19771385 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral peritoneal closure
Number of subjects: 620
Study 19771385 — intervention group
Group type: COMPARATOR
Intervention: Non-closure
Number of subjects: 620
Study 18456984 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuum of care services
Number of subjects: 157
Study 18456984 — intervention group
Group type: COMPARATOR
Intervention: Usual state-supported services
Number of subjects: 157
Study 16281743 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumonectomy
Number of subjects: 0
Study 12153550 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (dosage not specified)
Number of subjects: 447
Study 12153550 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 447
Study 12153550 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 447
Study 11468536 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus and corticosteroids (MMF-0 group, n=82)
Number of subjects: 232